Tan, D. H., Raboud, J. M., Kaul, R., Grinsztejn, B., Cahn, P., & Walmsley, S. L. (2010). Can herpes simplex virus type 2 suppression slow HIV disease progression: A study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial. BioMed Central.
Citación estilo ChicagoTan, Darrell HS, Janet M. Raboud, Rupert Kaul, Beatriz Grinsztejn, Pedro Cahn, and Sharon L. Walmsley. Can Herpes Simplex Virus Type 2 Suppression Slow HIV Disease Progression: A Study Protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) Trial. BioMed Central, 2010.
Cita MLATan, Darrell HS, et al. Can Herpes Simplex Virus Type 2 Suppression Slow HIV Disease Progression: A Study Protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) Trial. BioMed Central, 2010.